EP 1070066 A1 20010124 - SUBSTITUTED 1,2,4-TRIAZOLO 3,4-a PYRIDAZINE
Title (en)
SUBSTITUTED 1,2,4-TRIAZOLO 3,4-a PYRIDAZINE
Title (de)
SUBSTITUIERTE 1,2,4-TRIAZOLO¬3,4-A PYRIDAZINE
Title (fr)
1,2,4-TRIAZOLO 3,4-a PYRIDAZINE SUBSTITUEE
Publication
Application
Priority
- GB 9900485 W 19990217
- GB 9803992 A 19980225
- GB 9801307 W 19980506
- GB 9824896 A 19981112
Abstract (en)
[origin: WO9943677A1] A substituted triazolopyridazine derivative, its use in cognition enhancement therapy, compositions containing it and processes for its manufacture are disclosed.
IPC 1-7
IPC 8 full level
A61K 31/5025 (2006.01); A61P 25/28 (2006.01); C07D 487/04 (2006.01)
CPC (source: EP)
A61P 25/00 (2018.01); A61P 25/28 (2018.01); C07D 487/04 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated extension state (EPC)
AL LT LV MK RO SI
DOCDB simple family (publication)
WO 9943677 A1 19990902; AU 2536899 A 19990915; AU 746719 B2 20020502; BG 104705 A 20010430; CA 2317416 A1 19990902; CN 1291194 A 20010411; EA 002824 B1 20021031; EA 200000878 A1 20010226; EP 1070066 A1 20010124; HR P20000555 A2 20010831; HU P0100647 A2 20010928; HU P0100647 A3 20030328; JP 2002504554 A 20020212; NZ 505695 A 20020301; PL 341975 A1 20010507; SK 12772000 A3 20010312; TR 200002469 T2 20001221
DOCDB simple family (application)
GB 9900485 W 19990217; AU 2536899 A 19990217; BG 10470500 A 20000822; CA 2317416 A 19990217; CN 99803190 A 19990217; EA 200000878 A 19990217; EP 99905069 A 19990217; HR P20000555 A 20000825; HU P0100647 A 19990217; JP 2000533432 A 19990217; NZ 50569599 A 19990217; PL 34197599 A 19990217; SK 12772000 A 19990217; TR 200002469 T 19990217